<DOC>
	<DOCNO>NCT01391312</DOCNO>
	<brief_summary>This pilot study observe patient satisfaction BOTOX® Cosmetic treatment glabellar rhytides ( frown line ) use new treatment satisfaction measure .</brief_summary>
	<brief_title>Patient Satisfaction Study BOTOX® Cosmetic Treatment Moderate Severe Frown Lines</brief_title>
	<detailed_description />
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Moderate severe glabellar wrinkle ( frown line ) Previous treatment botulinum toxin therapy serotype Facial nonablative resurface laser light treatment , microdermabrasion , superficial peel within 3 month Any facial cosmetic procedure medium depth deep facial chemical peel ( e.g. , trichloroacetic acid phenol ) , midfacial periorbital laser skin resurface permanent makeup within 6 month Midfacial periorbital treatment nonpermanent soft tissue filler Subjects plan facial cosmetic procedure visible scar Previous cosmetic surgery upper face ( e.g. , prior periorbital surgery , facial lift , brow lift , eyelid lift eyebrow surgery ) Diagnoses Myasthenia Gravis , EatonLambert Syndrome , Amyotrophic Lateral Sclerosis History facial nerve palsy A plan extend absence study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>